The Situation
- A small pharma anti-infectives company needed help preparing for launch after receiving a CRL from the FDA.
The Solution
-
EVERSANA quickly downsized operations within five days of the company receiving a CRL.
-
Now the company has received an FDA approval two years later, EVERSANA is ready to scale back up and launch within six months.
The Results
- Five days time to pause operations.
- >$10M estimated savings by avoiding downsizing and then upsizing
on its own.